拉丁美洲国家新发的老年:来自墨西哥的多中心研究
Roberto A Suástegui Román1, Ángel Lee2, Laura E Hernández Vanegas3
1Emergency Service, Instituto Nacional de Neurología y Neurocirugía (INNN), Mexico City, Mexico.
概括
神经囊性 (NCC) 是拉丁美洲老年患者新发的一个重要原因. 财务限制影响治疗选择,突出需要价格合理的新型抗药物.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 在拉丁美洲,老年人的研究不足.
- 流行病学转变需要对老年的研究.
- 现实世界的数据对于理解当地环境至关重要.
研究的目的:
- 调查墨西哥新发老年的原因和治疗方法.
- 提供与国际文献形成鲜明对比的当地证据.
- 突出社会经济因素对治疗的影响.
主要方法:
- 从2007年至2018年对100名患有新发性老年 (发病年龄>60岁) 的患者进行了回顾性研究.
- 包括以前研究中具有相似特征的患者.
- 由神经病学家确认的诊断,包括脑电图和成像.
主要成果:
- 脑卒中 (42%) 和神经囊硬化症 (NCC) (10%) 是确定的原因.
- 在26%的病例中没有发现特定原因.
- 芬伊托因 (50%) 和卡巴马泽平 (25%) 是最常见的单一治疗药物.
结论:
- 在这个人群中,NCC是老年的普遍原因.
- 治疗选择受到经济限制的影响.
- 对于脆弱的老年患者来说,需要负担得起的新抗药物.
相关概念视频
Seizures: Classification
411
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
411
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Antiepileptic Drugs: Glutamate Antagonists
421
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
421
Antiepileptic Drugs: GABAergic Pathway Potentiators
460
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
460
Antiepileptic Drugs: Sodium Channel Blockers
664
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
664
Antiepileptic Drugs: Potassium Channel Activators
211
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
211


